Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Parkinson's Disease

  Free Subscription


25.12.2023

1 Ann Neurol
1 Biochemistry (Mosc)
1 BMC Neurosci
1 Exp Neurol
2 J Neural Transm (Vienna)
2 J Neurol Neurosurg Psychiatry
1 J Neurosci
2 Lancet Neurol
6 Mov Disord
1 Neurobiol Dis
1 Neurol Genet
2 Neurosci Lett
1 PLoS Comput Biol
2 PLoS One
2 Rev Neurol (Paris)


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Neurol

  1. REYNOSO A, Torricelli R, Jacobs BM, Shi J, et al
    Gene-environment interactions for Parkinson's disease.
    Ann Neurol. 2023 Dec 19. doi: 10.1002/ana.26852.
    PubMed         Abstract available


    Biochemistry (Mosc)

  2. NOVIKOV NI, Brazhnik ES, Kitchigina VF
    Pathological Correlates of Cognitive Decline in Parkinson's Disease: From Molecules to Neural Networks.
    Biochemistry (Mosc). 2023;88:1890-1904.
    PubMed         Abstract available


    BMC Neurosci

  3. DANIELYAN M, Nebogova K, Simonyan R, Hovsepyan A, et al
    Regulatory effect of bacterial melanin on the isoforms of new superoxide-producing associates from rat tissues in rotenone-induced Parkinson's disease.
    BMC Neurosci. 2023;24:69.
    PubMed         Abstract available


    Exp Neurol

  4. CORSI S, Scheggi S, Pardu A, Braccagni G, et al
    Corrigendum to "Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease" [Experimental neurology 2023 May;363:114370].
    Exp Neurol. 2023 Dec 15:114640. doi: 10.1016/j.expneurol.2023.114640.
    PubMed        


    J Neural Transm (Vienna)

  5. KIM S, Choi JH, Woo KA, Joo JY, et al
    Clinical correlates of pareidolias and color discrimination deficits in idiopathic REM sleep behavior disorder and Parkinson's disease.
    J Neural Transm (Vienna). 2023 Dec 18. doi: 10.1007/s00702-023-02724.
    PubMed         Abstract available

  6. SIMONETTA C, Bissacco J, Conti M, Bovenzi R, et al
    Motor cortex transcranial direct current stimulation improves non-motor symptoms in early-onset Parkinson's disease: a pilot study.
    J Neural Transm (Vienna). 2023 Dec 17. doi: 10.1007/s00702-023-02726.
    PubMed         Abstract available


    J Neurol Neurosurg Psychiatry

  7. GRONOSTAY A, Jost ST, Silverdale M, Rizos A, et al
    Stratifying quality of life outcome in subthalamic stimulation for Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2023 Dec 19:jnnp-2023-332272.
    PubMed         Abstract available

  8. PAULO DL, Johnson GW, Doss DJ, Allen JH, et al
    Intraoperative physiology augments atlas-based data in awake deep brain stimulation.
    J Neurol Neurosurg Psychiatry. 2023;95:86-96.
    PubMed         Abstract available


    J Neurosci

  9. LINDI SA, Mallet NP, Leblois A
    Synaptic changes in pallidostriatal circuits observed in parkinsonian model triggers abnormal beta synchrony with accurate spatio-temporal properties across the basal ganglia.
    J Neurosci. 2023 Dec 19:JN-RM-0419-23. doi: 10.1523/JNEUROSCI.0419-23.2023.
    PubMed         Abstract available


    Lancet Neurol

  10. MCGARRY A, Rosanbalm S, Leinonen M, Olanow CW, et al
    Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
    Lancet Neurol. 2024;23:37-45.
    PubMed         Abstract available

  11. TRENKWALDER C, Mollenhauer B
    The long road to neuroprotection for Parkinson's disease.
    Lancet Neurol. 2024;23:2-3.
    PubMed        


    Mov Disord

  12. MARANO M, Anzini G, Saltarocchi L, Ricciuti R, et al
    Left Vagus Stimulation Modulates Contralateral Subthalamic beta Power Improving the Gait in Parkinson's Disease.
    Mov Disord. 2023 Dec 18. doi: 10.1002/mds.29690.
    PubMed         Abstract available

  13. ESPAY AJ, Hauser RA, Dhall R, Thakkar S, et al
    Safety and Efficacy of IPX203 in Parkinson's Disease: The RISE-PD Open-Label Extension Study.
    Mov Disord. 2023 Dec 18. doi: 10.1002/mds.29685.
    PubMed         Abstract available

  14. MULLER T, Kuhn W
    An Indirect Proof for Levodopa-Induced Vitamin Deficiency in Parkinson's Disease.
    Mov Disord. 2023;38:2319-2320.
    PubMed        

  15. TUNOLD JA, Tan MMX, Toft M, Ross O, et al
    Lysosomal Polygenic Burden Drives Cognitive Decline in Parkinson's Disease with Low Alzheimer Risk.
    Mov Disord. 2023 Dec 20. doi: 10.1002/mds.29698.
    PubMed         Abstract available

  16. NAMBU A, Chiken S, Sano H, Hatanaka N, et al
    Dynamic Activity Model of Movement Disorders: The Fundamental Role of the Hyperdirect Pathway.
    Mov Disord. 2023;38:2145-2150.
    PubMed         Abstract available

  17. ZHENG Y, Cai H, Wang X, Zhang N, et al
    Erythrocytic alpha-Synuclein Species as Biomarkers for Isolated Rapid Eye Movement Sleep Behavior Disorder.
    Mov Disord. 2023;38:2315-2317.
    PubMed        


    Neurobiol Dis

  18. LIANG K, Li X, Guo Q, Ma J, et al
    Structural changes in the retina and serum HMGB1 levels are associated with decreased cognitive function in patients with Parkinson's disease.
    Neurobiol Dis. 2023;190:106379.
    PubMed         Abstract available


    Neurol Genet

  19. PANKRATZ N, Cole BR, Beutel KM, Liao KP, et al
    Parkinson Disease Genetics Extended to African and Hispanic Ancestries in the VA Million Veteran Program.
    Neurol Genet. 2023;10:e200110.
    PubMed         Abstract available


    Neurosci Lett

  20. RAJAN S, Sood A, Jain R, Kamatham PT, et al
    Fingolimod exerts neuroprotection by regulating S1PR1 mediated BNIP3-PINK1-Parkin dependent mitophagy in rotenone induced mouse model of Parkinson's disease.
    Neurosci Lett. 2023;820:137596.
    PubMed         Abstract available

  21. LIU H, Gong Z, Li Z, Ye T, et al
    Distribution, connection and function of ALDH1A1(+)/TH(+) neurons in substantia nigra pars reticulata of mouse.
    Neurosci Lett. 2024;818:137555.
    PubMed         Abstract available


    PLoS Comput Biol

  22. FLEMING JE, Pont Sanchis I, Lemmens O, Denison-Smith A, et al
    From dawn till dusk: Time-adaptive bayesian optimization for neurostimulation.
    PLoS Comput Biol. 2023;19:e1011674.
    PubMed         Abstract available


    PLoS One

  23. CHEN L, Xin G, He Y, Tian Q, et al
    Study of molecular patterns associated with ferroptosis in Parkinson's disease and its immune signature.
    PLoS One. 2023;18:e0295699.
    PubMed         Abstract available

  24. BORGHESI F, Mancuso V, Bruni F, Cremascoli R, et al
    Mental flexibility assessment: A research protocol for patients with Parkinson's Disease and Anorexia Nervosa.
    PLoS One. 2023;18:e0293921.
    PubMed         Abstract available


    Rev Neurol (Paris)

  25. ABILASHIMOVA D, Aubakirova M, Abdildin Y, Viderman D, et al
    Safinamide for pain management in patients with Parkinson's disease.
    Rev Neurol (Paris). 2023 Dec 15:S0035-3787(23)01143.
    PubMed         Abstract available

  26. BONAZ B
    The gut-brain axis in Parkinson's disease.
    Rev Neurol (Paris). 2023 Dec 20:S0035-3787(23)01149.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.